Clinical Trials for Black Diamond Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Black Diamond Therapeutics

Clinical Trials (1)

NCT05256290
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
PHASE1/PHASE2Active, not recruiting
200 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2026
10 conditions1 sponsor41 locations